Please use this identifier to cite or link to this item: http://hdl.handle.net/10362/120530
Title: Ventilatory defects and treatable traits in very elderly patients
Author: Gaspar-Marques, João
Palmeiro, Teresa
Caires, Iolanda
Leiria Pinto, Paula
Neuparth, N
Carreiro Martins, Pedro
Keywords: Aged
comorbidity
lung diseases
obstructive
respiratory disorders
SDG 3 - Good Health and Well-being
Issue Date: 1-May-2021
Abstract: Though the approach used to classify chronic respiratory diseases is changing to a treatable-traits (TT) approach, data regarding very elderly patients is lacking. The objectives of this study were to assess TT frequency in very elderly patients and to study the link between extrapulmonary TT and ventilatory defects. Individuals (≥75 years) residing in elderly care centres answered a standardised questionnaire, underwent spirometry, atopy and fractional exhaled nitric oxide assessments and had their blood pressure and peripheral pulse oximetry measured. Pulmonary, extrapulmonary and behavioural TT were evaluated. Outcome variables were an airflow limitation (post-bronchodilator z-score FEV1/FVC<-1.64) and a restrictive spirometry pattern (z-score FEV1/FVC ≥ +1.64 and z-score FVC<-1.64). Seventy-two percent of the individuals who took part in the study (n = 234) were women, and the median age of participants was 86 (IQR: 7.4). At least one pulmonary TT was identified in 105 (44.9%) individuals. The most frequent extrapulmonary TTs were: persistent systemic inflammation (47.0%), anaemia (34.4%), depression (32.5%) and obesity (27.4). Airflow limitation was exclusively associated with smoking (OR 5.03; 95% CI 1.56-16.22). A restrictive spirometry pattern was associated with cognitive impairment (OR: 3.89; 95% CI: 1.55-9.79). A high frequency of various TTs was found. The novel association between a restrictive spirometry pattern and cognitive impairment highlights the urgency of clinical research on this vulnerable age group.
Description: Funding: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was supported by AstraZeneca – Projecto OLDER (CEDOC/2015/59) and Finnee Project (PTDC/CCI-BIO/29702/2017).
Peer review: yes
URI: http://hdl.handle.net/10362/120530
DOI: https://doi.org/10.1177/00368504211013171
ISSN: 0036-8504
Appears in Collections:NMS: CHRC - Artigos em revista nacional com arbitragem científica

Files in This Item:
File Description SizeFormat 
00368504211013171.pdf303,97 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.